Harris Gerald J, Woo Kyung In
Section of Orbital and Ophthalmic Plastic Surgery, Department of Ophthalmology, Medical College Wisconsin, Milwaukee, USA.
Trans Am Ophthalmol Soc. 2003;101:93-103; discussion 103-5.
To describe the findings and outcomes in eosinophilic granuloma (unifocal Langerhans cell histiocytosis [LCH]) of the orbit, and to explain the paradox of aggressive bone destruction responsive to minimal intervention.
Retrospective, consecutive, interventional case series of patients treated from 1985 through 2001. Minimum inclusion criteria were demonstration of CD1a positivity or Birbeck granules, treatment by a single surgeon, systemic evaluation by a pediatric oncologist, and follow-up of 12 months. A pathogenetic construct was assembled from general LCH concepts and the specific orbital findings.
Seven patients met study criteria. All were male, 2 to 16 years of age. All had eyelid or forehead swelling and osteolytic defects, with symptoms of 2 to 6 weeks' duration. All underwent incisional biopsy, with frozen-section examination suggestive of LCH in 6 of 7 cases. The 2 earliest patients received low-dose irradiation after simple biopsy. The 5 most recent patients had subtotal curettage at the time of biopsy; 4 of 5 received simultaneous intralesional corticosteroid injection. In all cases, systemic evaluation showed no other focus of LCH, reossification was timely, and no local recurrence or additional focus was noted in follow-up of 1 to 17 years.
Transient immune dysfunction may provoke the cytokine-mediated proliferation of pathologic Langerhans cells within the hematopoietic marrow of the anterolateral frontal bone. These cells cause osteolysis through elaboration of interleukin-1 and prostaglandin E2. Corticosteroids can inhibit the mediators. We recommend incisional biopsy, frozen-section provisional diagnosis, subtotal curettage, intralesional corticosteroid instillation, postoperative systemic evaluation, and long-term follow-up.
描述眼眶嗜酸性肉芽肿(单灶性朗格汉斯细胞组织细胞增多症[LCH])的表现及治疗结果,并解释对微小干预有反应的侵袭性骨质破坏这一矛盾现象。
对1985年至2001年治疗的患者进行回顾性、连续性、干预性病例系列研究。最低纳入标准为CD1a阳性或存在伯贝克颗粒的证据、由单一外科医生治疗、由儿科肿瘤学家进行系统评估以及随访12个月。根据一般LCH概念和特定的眼眶表现构建了一个发病机制模型。
7例患者符合研究标准。均为男性,年龄2至16岁。均有眼睑或前额肿胀及溶骨性缺损,症状持续2至6周。均接受了切开活检,7例中有6例冰冻切片检查提示为LCH。最早的2例患者在单纯活检后接受了低剂量放疗。最近的5例患者在活检时进行了次全刮除术;5例中有4例同时接受了病灶内注射皮质类固醇。所有病例中,系统评估均未发现其他LCH病灶,骨再化及时,在1至17年的随访中未发现局部复发或其他病灶。
短暂的免疫功能障碍可能引发前外侧额骨造血骨髓内病理性朗格汉斯细胞的细胞因子介导的增殖。这些细胞通过分泌白细胞介素-1和前列腺素E2导致骨质溶解。皮质类固醇可抑制这些介质。我们建议进行切开活检、冰冻切片初步诊断、次全刮除术、病灶内注入皮质类固醇、术后系统评估及长期随访。